Distribution of systemically administered ampicillin, benzylpenicillin, and flucloxacillin in excisional wounds in diabetic and normal rats and effects of local topical vasodilator treatment

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 7, 1996, Pages 1703-1710

  Cross, Sheree E ^a   Thompson, Melanie J ^a   Roberts, Michael S ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; AMPICILLIN; FLUCLOXACILLIN; NITROPRUSSIDE SODIUM; PENICILLIN G; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; DIABETES MELLITUS; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; INFECTION; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT; SKIN ULCER; WOUND CONTRACTION; WOUND HEALING; WOUND HEALING IMPAIRMENT;

EID: 0029973366     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.7.1703     Document Type: Article

References (47)

1. Apelqvist, J., and C.-D. Agardh. 1992. The association between clinical risk factors and outcome of diabetic foot ulcers. Diabetes Res. Clin. Pract. 18: 43-53.
2. Apelqvist, J., J. Larson, and C.-D. Agardh. 1992. Medical risk factors in diabetic patients with foot ulcers and severe peripheral vascular disease and their outcome. J. Diabetes Complications 6:167-174.
3. Avery's Drug Treatment. 1987. In T. M. Speight (ed.), 3rd ed., p. 1358-1380. ADIS Press, Auckland.
4. Cameron, N. E., M. A. Cotter, and P. A. Low. 1991. Nerve blood flow in early experimental diabetes in rats: relation to conduction deficits. Am. J. Physiol. 261 (Endocrinol. Metab. 24):E1-E8.
5. Cameron, N. E., M. A. Cotter, and E. K. Maxfield. 1993. Anti-oxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats. Diabetologia 36:299-304.
6. Carrs, O. 1991. Pharmacokinetics of antibiotics in tissues and tissue fluids: a review. Scand. J. Infect. Dis. 74(Suppl.):23-33.
7. Cross, S. E., I. L. Naylor, R. A. Coleman, and T. C. Teo. 1995. An experimental model to investigate the dynamics of wound contraction. Br. J. Plast. Surg. 48:189-197.
8. Cross, S. E., Z. Wu, and M. S. Roberts. 1994. Effect of perfusion flow rate on the tissue uptake of solutes after dermal application using the rat isolated perfused hindlimb preparation. J. Pharm. Pharmacol. 46:844-850.
9. Duckworth, C., J. F. Fisher, S. A. Carter, C. L. Newman, C. Cogburn, R. R. Nesbit, and C. H. Wray. 1993. Tissue penetration of clindamycin in diabetic foot infections. J. Antimicrob. Chemother. 31:581-584.
10. Fahey, T. J., A. Sadaty, W. G. Jones, A. Barber, B. Smoller, and G. T. Shires. 1991. Diabetes impairs the late inflammatory response to wound healing. J. Surg. Res. 50:308-313.
11. Figliomeni, B., B. Bacci, C. Panozzo, F. Fogarolo, C. Triban, and M. G. Fiori. 1992. Experimental diabetic neuropathy. Effect of ganglioside treatment on axonal transport of cytoskeletal proteins. Diabetes 41:866-871.
12. Furchgott, R. F. 1984. The role of endothelium in the responses of vascular smooth muscle to drugs. Annu. Rev. Pharmacol. Toxicol. 24:175-197.
13. Furchgott, R. F., and J. V. Zawadzki. 1980. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (London) 288:273-276.
14. Gerding, D. N., and W. H. Hall. 1975. The penetration of antibiotics into peritoneal fluid. Bull. N. Y. Acad. Med. 51:1016-1019.
15. Goodson, W. H., and T. K. Hunt. 1979. Wound healing in the diabetic patient. Surg. Gynecol. Obstet. 149:600-664.
16. Goodson, W. H., and T. K. Hunt. 1986. Wound collagen accumulation in obese hyperglycemic mice. Diabetes 35:491-495.
17. Hennessey, P. J., E. G. Ford, T. Black, and R. J. Andrassy. 1990. Wound collagenase activity correlates directly with collagen glycosylation in diabetic rats. J. Pediat. Surg. 25:75-78.
18. Hotta, N., H. Kakuta, H. Fukasawa, N. Koh, F. Sakakibara, H. Komori, and N. Sakamoto. 1992. Effect of niceritrol on streptozotocin-induced diabetic neuropathy in rats. Diabetes 41:587-591.
19. Howell, A., R. Sutherland, and G. N. Rolinson. 1972. Effect of protein binding levels of ampicillin and cloxacillin in synovial fluid. Clin. Pharmacol. Ther. 13:724-732.
20. Hutchinson, K. J., B. W. Johnson, H. T. Williams, and G. D. Brown. 1974. The histamine flare response in diabetes mellitus. Surg. Gynecol. Obstet. 139:566-568.
21. Kiff, R. J., S. M. Gardiner, A. M. Compton, and T. Bennett. 1991. The effects of endothelin-1 and NG-nitro-L-arginine methyl ester on regional haemodynamics in conscious rats with streptozotocin-induced diabetes mellitus. Br. J. Pharmacol. 103:1321-1326.
22. Lishner, M., R. Lang, I. Kedar, and M. Ravid. 1985. Treatment of diabetic perforating ulcers (mal perforant) with local dimethylsulfoxide. J. Am. Geriatr. Soc. 33:41-43.
23. Louie, T. J., J. G. Bartlett, F. P. Tally, and S. L. Gorbach. 1976. Aerobic and anaerobic bacteria in diabetic foot ulcers. Ann. Intern. Med. 85:461-463.
24. Macioce, P., G. Filliatreau, B. Figliomeni, R. Hassig, J. Thiery, and L. D. Giamberardino. 1989. Slow axonal transport impairment of cytoskeletal proteins in streptozotocin-induced diabetic neuropathy. J. Neurochem. 53:1261-1267.
25. Malone, J. I., S. Lowitt, N. Corsico, and Z. Orfalian. 1992. Altered neuroexcitability in experimental diabetic neuropathy: effect of acetyl-1-carnitine. Int. J. Clin. Pharm. Res. 12:237-241.
26. McMurry, J. F. 1984. Wound healing with diabetes mellitus: better glucose control for better wound healing in diabetes. Surg. Clin. North. Am. 64:769-774.
27. Monafo, W. W., S. G. Eliasson, S. Shimazaki, and H. Sugimoto. 1988 Regional blood flow in resting and stimulated sciatic nerve of diabetic rats. Exp. Neurol. 99:607-614.
28. Palmer, R. M. J., A. G. Ferrige, and S. Moncada. 1987. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature (London) 327:524-527.
29. Parkhouse, N., and P. M. Le Quesne. 1986. Laser doppler measurement of acetylcholine-induced axon reflex flare to assess nociceptive c-fibre function. J. Physiol. (London) 381:3P.
30. Parkhouse, N., and P. M. Le Quesne. 1988. Impaired neurogenic vascular response in patients with diabetes and neuropathic foot lesions. N. Engl. J. Med. 318:16-1309.
31. Prakash, A., P. N. Pandit, and L. K. Sharma. 1974. Studies in wound healing in diabetes. Int. Surg. 59:25-28.
32. Rayman, G., S. A. Williams, P. D. Spencer, L. H. Smaje, P. H. Wise, and J. E. Tooke. 1986. Impaired microvascular hyperaemic response to minor skin trauma in type I diabetes. Br. Med. J. 292:1295-1298.
33. Robertson, S., N. E. Cameron, and M. A. Cotter. 1992. The effect of the calcium antagonist nifedipine on peripheral nerve function in streptozotocin-diabetic rats. Diabetologia 35:1113-1117.
34. Rosenberg, C. S. 1990. Wound healing in the patient with diabetes mellitus. Nurs. Clin. N. Am. 25:247-261.
35. Scher, K. S., and F. J. Steele. 1988. The septic foot in patients with diabetes. Surgery 104:661-666.
36. Seabrook, G. R., C. E. Edminston, D. D. Schmitt, C. Krepel, D. F. Bandyk, and J. B. Towne. 1991. Comparison of serum and tissue antibiotic levels in diabetes-related loot infections. Surgery 110:671-677.
37. Sharp, C. S., A. N. Bessman, F. W. Wagner, D. Garland, and E. Reece. 1979. Microbiology of superficial and deep tissues in infected diabetic gengrene. Surg. Gynecol. Obstet. 149:217-219.
38. Shindo, H., M. Tawata, and T. Onaya. 1993. Cyclic adenosine 3′,5′-monophosphate enhances sodium, potassium-adenosine triphosphatase activity in the sciatic nerve of streptozotocin-induced diabetic rats. Endocrinol. 132: 510-516.
39. Shyu, W. C., R. Quintiliani, C. H. Nightingale, and M. N. Dudley. 1988. Effect of protein binding on drug penetration into blister fluid. Antimicrob. Agents Chemother. 32:128-130.
40. Singh, P., arid M. S. Roberts. 1994. Iontophoretic transdermal delivery of salicylic acid and lidocaine to local subcutaneous structures. J. Pharm. Sci. 82:127-131.
41. Storm, A. J., K. P. Bouter, R. J. A. Diepersloot, J. D. Banga, R. G. Beerens, and D. W. Erkelens. 1994. Tissue concentrations of an orally administered antibiotic in diabetic patients with fool infections. J. Antimicrob. Chemother. 34:449-451.
42. Tan, J. S., A. Trutt, J. P. Phair, and C. Watanakunakorn. 1972. A method for measurement of antibiotics in human interstitial fluid. J. Infect. Dis. 126: 492-497.
43. Tooke, J. E., P. E. Lins, J. Östergren, and B. Fagrell. 1985. Skin microvascular autoregulatory responses in Type I diabetes: the influence of duration and control. Int. J. Microcirc. Clin. Exp. 4:249-256.
44. Waterman, N. G., M. J. Raff, L. Scharfenberger, and P. A. Barnwell. 1976. Protein binding and concentrations of cephaloridine and cefazolin in serum and interstitial fluid in dogs. J. Infect. Dis. 133:642-647.
45. Westerman, R. A., R. E. Widdop, C. Hogan, and P. Zimmet. 1987. Non-invasive tests of neurovascular function: reduced responses in diabetes mellitus. Neurosci. Lett. 81:177-182.
46. Wise, R., A. P. Gillett, B. Cadge, S. R. Durham, and S. Baker. 1980. The influence of protein binding upon tissue fluid levels of six β-lactam antibiotics. J. Infect. Dis. 142:77-82.
47. Yasuda, H., M. Sonobe, T. Hisanaga, T. Kawabata, K. Maeda, R. Kikkawa, and Y. Shigeta. 1992. A combination of aldose reductase inhibitor, statil, and the prostaglandin E1 analogue, OP1206.αCD, completely improves sciatic motor nerve conduction velocity in streptozotocin-induced diabetic rats. Metabolism 41:778-782.